Safety and Immunogenicity of Quadrivalent Recombinant Influenza Vaccine Formulations Containing Different H3 Hemagglutinin Antigens in Healthy Adult Subjects 18 to 30 Years of Age
PHASE1
The primary objectives of the study are:
* To describe the safety profile ...
Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and Older
PHASE1
Study VBT00002 is planned to be a Phase 1/2, randomized, modified double-bl...
Status
Completed
Location
Central Phoenix Medical Clinic- Site Number : 8400009